07/06/2022 - Research

The IGTP and the Clinical Laboratory North Metropolitan Area are the first to publish the complete sequence of a sample of monkey pox virus

The IGTP and the Microbiology Service of the Clinical Laboratory of the North Metropolitan Area led by the researcher Elisa Martró have been the first to carry out the complete sequencing of a sample of monkey pox virus in Spain. This is a milestone in itself, but will also be fundamental for epidemiological surveillance of the infection and the study of future outbreaks as it provides a description of the genetic material of the virus.

07/06/2022 - Research

The CMCiB awarded the certificate for Good Laboratory Practice (GLP) for preclinical research

The Centre for Comparative Medicine and Bioimage (CMCiB) of the Germans Trias I Pujol Research Institute has been awarded the certificate for complying with good laboratory practices (GLP) in line with the European Directive 2004/9/CE. The centre complies with the principles established by the Spanish Royal Decree 822/19932 for carrying out preclinical studies with healthcare products (analytical tests, clinical chemistry - haematology and biochemistry - in studies administrating trial products, obtaining samples and biocompatibility of healthcare products). The areas certified are the surgical and bioimage areas, including the technology of vascular radiology interventions, ultrasound scan and magnetic resonance.

28/04/2022 - Innovation

On the Erasmus+ program and digitalization in learning

The Germans Trias i Pujol Research Institute (IGTP) and the Germans Trias Hospital have taken part for the first time in the Erasmus+ Programme with an ambitious project aimed at digitalizing student stays at the centre. The 4D Digitalisation of Learning Project aims to design mobile technology that improves learning for students taking a nursing degree an improve the communication between the healthcare centre and the university to enrich the student experience.

25/04/2022 - Innovation

Banco Sabadell invests in Time is Brain through the 4th Banco Sabadell call

The IGTP spin-off has developed a medical device to improve the diagnosis of acute ischaemic stroke. This is the second investment made within the BStartup Health Call for which 121 start-ups applied.

21/03/2022 - Research

No increased risk of diabetes type 1 for children of women treated with betamethasone during pregnancy

The Immunology of Diabetes group have published a study evaluating the effect of prenatal exposure to betamethasone on the risk of developing diabetes type 1 in the Journal of Diabetes Research.

17/03/2022 - Research

Researchers from Germans Trias and Mateu Orfila Hospital in Menorca identify a new subtype of ataxia

The article describing the new SCA49 subtype has been published in the journal Brain Communications, and is featured as a highlight by its Editorial Board. The new ataxia subtype has been identified by studying members of one family from the island of Menorca. The finding provides a better understanding of the pathological basis of ataxia and opens the door to pre-symptomatic diagnoses and genetic counselling for people with the disorder.

15/03/2022 - Innovation

Nimble Diagnostics is founded to monitor stents using microwave technology

The device will identify possible obstructions in stents quickly and non-invasively. Nimble is a spin-off company of the Germans Trias i Pujol Research Institute (IGTP), the Universitat Politècnica de Catalunya (UPC) and the University of Barcelona (UB).

03/03/2022 - Research

New biomarkers to monitor and predict the remission phase (honeymoon) in children with type 1 diabetes

A study led by researchers from the Germans Trias i Pujol Research Institute (IGTP) and the Parc Tauli Hospital published in Frontiers in Immunology shows that a sample of peripheral blood can be used to identify levels of cells and molecules of the immune system that are specifically altered during the remission phase in paediatric type 1 diabetes (T1D). These can be used to monitor this phase and predict the progress of the disease.

22/02/2022 - Research

The GCAT|Panel is the first complete genetic map of the Iberian population that helps identifying possible genetic causes of common diseases

The panel is the result of a collaboration between the GCAT|Genomes for Life Cohort of the IGTP and the Barcelona Supercomputing Center. Massive genome sequencing of a sample of healthy members of the population has made it possible to provide a genetic tool to study complex variants in the genome that can potentially cause common diseases. The panel will allow researchers using low-cost sequencing techniques to improve the discovery and interpretation of the genetic changes behind common diseases more easily

18/02/2022 - Research

The generation of human neurofibromas in mice opens the door to testing new treatments

The Hereditary Cancer Group have published a study in Cell Reports in which they describe the generation of a model system based on induced pluripotent stem cells (iPSCs) that is able to generate human neurofibromas in mice. These tumours arise in people with the genetic disease Neurofibromatosis Type 1, a prevalent condition occurring in one in every 3,000 people. To date, a robust method for generating human neurofibromas in mice has been lacking, and the model developed opens up the possibility of testing new treatments for these tumours.